[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69837265D1 - Polypeptide zur regenerierung des nervensystems - Google Patents

Polypeptide zur regenerierung des nervensystems

Info

Publication number
DE69837265D1
DE69837265D1 DE69837265T DE69837265T DE69837265D1 DE 69837265 D1 DE69837265 D1 DE 69837265D1 DE 69837265 T DE69837265 T DE 69837265T DE 69837265 T DE69837265 T DE 69837265T DE 69837265 D1 DE69837265 D1 DE 69837265D1
Authority
DE
Germany
Prior art keywords
polypeptides
nervous system
regenerating
useful
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69837265T
Other languages
English (en)
Other versions
DE69837265T2 (de
Inventor
Annie Meiniel
Hubert Monnerie
Stephane Gobron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEURONAX
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
NEURONAX
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEURONAX, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical NEURONAX
Application granted granted Critical
Publication of DE69837265D1 publication Critical patent/DE69837265D1/de
Publication of DE69837265T2 publication Critical patent/DE69837265T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69837265T 1997-07-16 1998-07-16 Polypeptide zur regenerierung des nervensystems Expired - Lifetime DE69837265T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9709016A FR2766190B1 (fr) 1997-07-16 1997-07-16 Nouveaux peptides et polypeptides utiles dans la regeneration du systeme nerveux
FR9709016 1997-07-16
PCT/FR1998/001556 WO1999003890A1 (fr) 1997-07-16 1998-07-16 Nouveaux peptides et polypeptides utiles dans la regeneration du systeme nerveux

Publications (2)

Publication Number Publication Date
DE69837265D1 true DE69837265D1 (de) 2007-04-19
DE69837265T2 DE69837265T2 (de) 2007-11-15

Family

ID=9509272

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69837265T Expired - Lifetime DE69837265T2 (de) 1997-07-16 1998-07-16 Polypeptide zur regenerierung des nervensystems

Country Status (10)

Country Link
US (1) US6995140B1 (de)
EP (1) EP1003784B1 (de)
JP (1) JP2001510034A (de)
AT (1) ATE356145T1 (de)
AU (1) AU8811298A (de)
CA (1) CA2297303C (de)
DE (1) DE69837265T2 (de)
ES (1) ES2281132T3 (de)
FR (1) FR2766190B1 (de)
WO (1) WO1999003890A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2910003B1 (fr) * 2006-12-18 2012-10-26 Neuronax Nouveaux peptides et polypeptides a stabilite amelioree utiles dans la regeneration du systeme nerveux
EP2027868A1 (de) * 2007-08-24 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von SCO-Spondin zur Hemmung oder Verhinderung von durch Zelltod-Rezeptor-Liganden vermittelter Apoptose
FR3024364B1 (fr) * 2014-07-31 2016-09-02 Neuronax Oligopeptides particuliers comme medicaments anti-angiogeniques
FR3041644B1 (fr) * 2015-09-25 2018-01-05 Neuronax Polypeptides cycliques, leur procede d'obtention et leur application en therapeutique
EP3330284A1 (de) * 2016-12-05 2018-06-06 Neuronax Sa Verwendung von peptidverbindungen zur förderung des überlebens, des wachstums und der zelldifferenzierung
EP3360884A1 (de) 2017-02-10 2018-08-15 Neuronax Verbessertes verfahren zur herstellung eines dodecapeptids
JP2022552217A (ja) 2019-10-07 2022-12-15 アクソルティス・ファーマ 脊髄損傷の治療のため及び／又は髄鞘再形成のためのペプチドの全身投与
KR20220110278A (ko) 2019-12-05 2022-08-05 아쏠티스 파마 타우병증을 치료하기 위한 펩타이드 조성물 및 방법
WO2023280550A1 (en) 2021-07-09 2023-01-12 Axoltis Pharma Sco-spondin-derived polypeptides for enhancing synaptic transmission
EP4190347A1 (de) 2021-12-01 2023-06-07 Axoltis Pharma Von sco-spondin abgeleitete polypeptide zur behandlung der dysfunktion biologischer barrieren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
FR2678283A1 (fr) 1991-06-25 1992-12-31 Centre Nat Rech Scient Sequences de nucleotides, sequences d'acides amines correspondantes, et leurs applications biologiques.
WO1994006464A1 (en) * 1992-09-17 1994-03-31 New York University Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites

Also Published As

Publication number Publication date
AU8811298A (en) 1999-02-10
JP2001510034A (ja) 2001-07-31
US6995140B1 (en) 2006-02-07
CA2297303C (fr) 2012-02-21
DE69837265T2 (de) 2007-11-15
ES2281132T3 (es) 2007-09-16
WO1999003890A1 (fr) 1999-01-28
FR2766190A1 (fr) 1999-01-22
EP1003784A1 (de) 2000-05-31
CA2297303A1 (fr) 1999-01-28
ATE356145T1 (de) 2007-03-15
FR2766190B1 (fr) 2001-11-02
EP1003784B1 (de) 2007-03-07

Similar Documents

Publication Publication Date Title
DE69735375D1 (de) Genfamilie von apoptose-verwandten peptiden, dadurch kodierte peptide und verfahren zu deren herstellung
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
ATE133681T1 (de) Mykobakterielle rekombinanten und peptide
DE60132075D1 (de) Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
WO1995021919A3 (en) Protein having tpo activity
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
DE60218179D1 (de) Peptide zur behandlung von tumoren und anderen bedingungen die die entfernung oder zerstörung von zelle erfordern
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
GB8821785D0 (en) Peptide compounds
WO1995030001A3 (en) Novel p-selectin ligand protein
DE69233245D1 (de) Verfahren zur Herstellung von Peptiden
DE59712235D1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DE69524415D1 (de) UNGESPLEISSTE VARIANTEN DES gp350/220
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
ATE325812T1 (de) Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors
FR2792651A1 (fr) Sequence genomique et polypeptides de pyrococcus abyssi, leurs fragments et leurs utilisations
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DK0811068T3 (da) Humane DNase I varianter
NZ510812A (en) Novel peptides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition